Abstract
As a malignant tumor, gastric cancer (GC) is closely related with gastric mucosa and has a high mortality in the world. Since microRNA (miRNA) has become more and more important in tumor research, we intend to find out the functional role and mechanism of miR-511-5p in GC. Firstly, miR-511-5p level was examined in human GC cell lines and tissues, and its effect on cell migration and invasion of BGC-823 or HGC-27 cells was tested by migration assay and transwell assay. Then, we confirmed the association between miR-511-5p and p21 activated kinase 2 (PAK2) by the luciferase reporter assay, and further assessed their role in cell migration and invasion. Moreover, we verified the function of miR-511-5p and PAK2 in epithelial–mesenchymal transition (EMT). In our study, miR-511-5p was downregulated in GC cell lines and tissues, and inversely associated with PAK2. Luciferase reporter assay confirmed that miR-511-5p could bind to PAK2. MiR-511-5p mimics significantly upregulated E-cadherin and downregulated N-cadherin, Vimentin and Snail, and consequently inhibited cell migration and invasion. However, reintroduction of PAK2 reversed the inhibitory function of miR-511-5p on BGC-823 and HGC-27 cells. Our research suggested that tumor-suppressive function of miR-511-5p in GC was inhibited by PAK2, and miR-511-5p/PAK2 axis may serve as a new strategy in GC management.
Similar content being viewed by others
Data Availability
All data generated or analyzed during this study are included in this published article.
Abbreviations
- EMT:
-
Epithelial–mesenchymal transition
- GADPH:
-
Glyceraldehyde-3-phosphate dehydrogenase
- GC:
-
Gastric cancer
- GEC-1:
-
Normal gastric epithelial cell lines
- miRNA:
-
microRNA
- MMPs:
-
Matrix metalloproteinases
- NC:
-
Negative control
- PAGE:
-
Polyacrylamide gels electrophoresis
- PAK2:
-
P21 activated kinase 2
- PVDF:
-
Polyvinylidene fluoride
- qRT-PCR:
-
Quantitative real-time polymerase chain reaction
- SDS:
-
Sodium dodecylsulfate
References
Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 13:790–801. https://doi.org/10.1016/S1470-2045(12)70211-5
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132. https://doi.org/10.3322/caac.21338
Chen XB, Li W, Chu AX (2019) MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial–mesenchymal transition process by targeting presenilin 1. J Cell Biochem 120:470–480. https://doi.org/10.1002/jcb.27403
Cho HJ, Baek KE, Kim IK, Park SM, Choi YL, Nam IK et al (2012) Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer. J Proteome Res 11:2355–2364. https://doi.org/10.1021/pr2011186
Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E et al (2012) The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets 16:S103–S109. https://doi.org/10.1517/14728222.2011.650632
Cory G (2011) Scratch-wound assay. Cell migration. Springer, Berlin, pp 25–30
Fang Z, Zhang L, Liao Q, Wang Y, Yu F, Feng M et al (2017) Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer. J Exp Clin Cancer Res 36:17. https://doi.org/10.1186/s13046-017-0489-1
Gao C, Ma T, Pang L, Xie R (2014) Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer. Diagn Pathol 9:55. https://doi.org/10.1186/1746-1596-9-55
Hamano S, Mori Y, Aoyama M, Kataoka H, Tanaka M, Ebi M et al (2015) Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells. Cancer Lett 356:846–854. https://doi.org/10.1016/j.canlet.2014.10.046
He S, Wang G, Ni J, Zhuang J, Zhuang S, Wang G et al (2018) MicroRNA-511 inhibits cellular proliferation and invasion in colorectal cancer by directly targeting hepatoma-derived growth factor. Oncol Res Featur Preclin Clin Cancer Ther 26:1355–1363. https://doi.org/10.3727/096504018X15154094331876
Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma H et al (2015) MiR-338-3p inhibits epithelial–mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget 6:15222. https://doi.org/10.18632/oncotarget.3835
Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E (2011) Breast cancer and microRNAs: therapeutic impact. The Breast 20:S63–S70. https://doi.org/10.1016/S0960-9776(11)70297-1
Jakobi R, Moertl E, Koeppel MA (2001) p21-activated protein kinase γ-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J Biol Chem 276:16624–16634. https://doi.org/10.1074/jbc.M007753200
Jiang C, Chen X, Alattar M, Wei J, Liu H (2015) MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther 22:291. https://doi.org/10.1038/cgt.2015.19
Kumar R, Vadlamudi RK (2002) Emerging functions of p21-activated kinases in human cancer cells. J Cell Physiol 193:133–144. https://doi.org/10.1002/jcp.10167
Kumar R, Gururaj AE, Barnes CJ (2006) p21-activated kinases in cancer. Nat Rev Cancer 6:459. https://doi.org/10.1038/nrc1892
Li X, Wen W, Liu K, Zhu F, Malakhova M, Peng C et al (2011) Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines. J Biol Chem 286:22291–22299. https://doi.org/10.1074/jbc.M111.236596
Li J, Zou K, Yu L, Zhao W, Lu Y, Mao J et al (2018) MicroRNA-140 inhibits the epithelial–mesenchymal transition and metastasis in colorectal cancer. Mol Ther Nucleic Acids 10:426–437. https://doi.org/10.1016/j.omtn.2017.12.022
Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei W-Q, Qiao Y-L et al (2011) Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol 17:4421. https://doi.org/10.3748/wjg.v17.i39.4421
Liu H, Shin SH, Chen H, Liu T, Li Z, Hu Y et al (2020) CDK12 and PAK2 as novel therapeutic targets for human gastric cancer. Theranostics 10:6201–6215. https://doi.org/10.7150/thno.46137
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Marlin JW, Eaton A, Montano GT, Chang Y-WE, Jakobi R (2009) Elevated p21-activated kinase 2 activity results in anchorage-independent growth and resistance to anticancer drug-induced cell death. Neoplasia (New York, NY) 11:286–297. https://doi.org/10.1593/neo.81446
Miyahara R, Niwa Y, Matsuura T, Maeda O, Ando T, Ohmiya N et al (2007) Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years. J Gastroenterol Hepatol 22:1435–1442. https://doi.org/10.1111/j.1440-1746.2007.04991.x
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in five continents, vol VIII. IARC Scientific Publications, Lyon, p 155
Peng Y, Liu Y-M, Li L-C, Wang L-L, Wu X-L (2014) MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PLoS ONE 9:e94422. https://doi.org/10.1371/journal.pone.0094422
Qiao Y, Jiang X, Lee ST, Karuturi RKM, Hooi SC, Yu Q (2011) FOXQ1 regulates epithelial–mesenchymal transition in human cancers. Cancer Res 71:3076–3086. https://doi.org/10.1158/0008-5472.CAN-10-2787
Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M, Gentilini M et al (2019) Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut 68:11–17. https://doi.org/10.1136/gutjnl-2017-314600
Ryu HS, Park DJ, Kim HH, Kim WH, Lee HS (2012) Combination of epithelial–mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol 43:520–528. https://doi.org/10.1016/j.humpath.2011.07.003
Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP (2018) Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 10:239–248. https://doi.org/10.2147/CMAR.S149619
Siu MKY, Wong ESY, Chan HY, Kong DSH, Woo NWS, Tam KF et al (2010) Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Int J Cancer 127:21–31. https://doi.org/10.1002/ijc.25005
Venerito M, Link A, Rokkas T, Malfertheiner P (2016) Gastric cancer—clinical and epidemiological aspects. Helicobacter 21:39–44. https://doi.org/10.1111/hel.12339
Wang S, Han H, Hu Y, Yang W, Lv Y, Wang L et al (2018) MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma. Mol Carcinog 57:383–392. https://doi.org/10.1002/mc.22762
Widmann C, Gibson S, Johnson GL (1998) Caspase-dependent cleavage of signaling proteins during apoptosis: a turn-off mechanism for anti-apoptotic signals. J Biol Chem 273:7141–7147. https://doi.org/10.1074/jbc.273.12.7141
Yang X, Liu L, Zou H, Zheng Y-W, Wang K-P (2019) circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma. Dig Liver Dis 51:1446–1455. https://doi.org/10.1016/j.dld.2019.04.012
Zhang SQ, Yang Z, Cai XL, Zhao M, Sun MM, Li J et al (2017) miR-511 promotes the proliferation of human hepatoma cells by targeting the 3′ UTR of B cell translocation gene 1 (BTG1) mRNA. Acta Pharmacol Sin 38:1161–1170. https://doi.org/10.1038/aps.2017.62
Acknowledgements
We would like to give our sincere gratitude to the reviewers for their constructive comments.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Informed Consent
The informed consent obtained from study participants.
Research Involving Human and/or Animal Rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
10528_2021_10126_MOESM1_ESM.tif
Supplementary file1 (TIF 313 kb) Figure S1. Western blot analysis was used to detected PAK2 protein level in GC tissues. Results were shown as the mean ± SD of three separated exams. **p < 0.01.
Rights and permissions
About this article
Cite this article
Yong, W., Zhang, K., Deng, Y. et al. miR-511-5p Suppresses Cell Migration, Invasion and Epithelial–Mesenchymal Transition Through Targeting PAK2 in Gastric Cancer. Biochem Genet 60, 899–913 (2022). https://doi.org/10.1007/s10528-021-10126-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-021-10126-y